Delphi Ventures was founded over 25 years ago as one of the first venture capital firms to focus on investing in life sciences companies.
Delphi Ventures is a venture capital firm that has focused on investing in biotechnology and medical devices for over two decades. With more than $1.1 billion in committed capital, Delphi Ventures has funded over 170 companies. More than 110 of our portfolio companies have either completed an initial public offering or have been acquired by a leading healthcare corporation.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 13, 2022
Friktion Labs
|
Series Unknown | $5.50M | Blockchain | — |
Sep 13, 2021
RECUR
|
Series A | $50M | Blockchain | — |
Aug 5, 2021
Tessera
|
Seed | $7.90M | Blockchain | — |
Jun 4, 2021
Pontem Network
|
Series Unknown | $4.50M | Blockchain | — |
Mar 24, 2021
XDEFI Wallet
|
Seed | $1.20M | Cryptocurrency | — |